صفحة النتائج 2 القطاع: الرعاية الصحية الصناعة: شركات تصنيع الأدوية - عامة سوق الأسهم - العروض والأسعار
قائمة بجميع الأوراق المالية والأسهم مع الأسعار، والقيم السوقية، ونسبة السعر إلى الربح، والأرباح للسهم الواحد
جميع البلدان
- {{country.name}}
- جميع البلدان
- الولايات المتحدة (50)
- الأرجنتين (13)
- أستراليا (1)
- النمسا (13)
- البرازيل (14)
- كندا (2)
- تشيلي (4)
- الصين (22)
- فنلندا (2)
- فرنسا (3)
- ألمانيا (58)
- هونغ كونغ (4)
- هنغاريا (1)
- الهند (20)
- إندونيسيا (1)
- إيطاليا (5)
- اليابان (9)
- المكسيك (14)
- سنغافورة (1)
- كوريا الجنوبية (3)
- إسبانيا (1)
- السويد (3)
- سويسرا (6)
- تايوان (1)
- تركيا (1)
- المملكة المتحدة (20)
جميع منصات التبادل
- {{item.name}}
- جميع منصات التبادل
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
الرعاية الصحية (279)
- {{item.name}}
- جميع القطاعات
- الرعاية الصحية (279)
شركات تصنيع الأدوية - عامة (279)
- {{item.name}}
- جميع الصناعات
- التكنولوجيا الحيوية (2611)
- شركات تصنيع الأدوية - عامة (279)
- شركات تصنيع الأدوية - متخصصة وعامة (1705)
- خطط الرعاية الصحية (57)
- منشآت الرعاية الطبية (553)
- متاجر التجزئة الصيدلانية (155)
- خدمات المعلومات الصحية (419)
- الأجهزة الطبية (913)
- الأدوات والمستلزمات الطبية (501)
- التشخيص والبحث (427)
- التوزيع الطبي (138)
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS |
|---|
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLYC.VI | $650.5 711.08 USD |
-5.06
|
$584.14B 638.55B USD | $188 205.51 USD | $623.3 681.35 USD | $650.5 711.08 USD | $584.14B 638.55B USD | 60.45 | $10.76 11.76 USD | |
| Johnson & Johnson JNJ.BA | $13,675 16.16 USD |
-2.67
|
$397.49T 469.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $397.49T 469.84B USD | 10.99 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,255 192.74 USD |
+1.97
|
$7.84T 464.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $7.84T 464.46B USD | 28.16 | $115.55 6.84 USD | |
| Johnson & Johnson JNJB34.SA | $59.67 12.09 USD |
-0.58
|
$2.16T 437.17B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.16T 437.17B USD | 27.49 | $2.17 0.44 USD | |
| AbbVie Inc. ABBV.BA | $24,925 29.46 USD |
-6.21
|
$354.62T 419.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $354.62T 419.18B USD | 9.70 | $2.57K 3.03 USD | |
| AbbVie Inc. ABBV.MX | $3,912 231.64 USD |
-2.88
|
$6.92T 409.76B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.92T 409.76B USD | 81.96 | $47.73 2.83 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $67.69 13.72 USD |
-4.24
|
$1.92T 388.32B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.92T 388.32B USD | 80.58 | $0.84 0.17 USD | |
| Johnson & Johnson JNJ.F | $139.9 152.93 USD |
-0.55
|
$337.14B 368.54B USD | $1.91K 2.09K USD | $133.5 145.93 USD | $139.9 152.93 USD | $337.14B 368.54B USD | 26.64 | $5.25 5.74 USD | |
| Johnson & Johnson JNJ.VI | $138.9 151.84 USD |
-2.05
|
$334.73B 365.9B USD | $622 679.93 USD | $134.82 147.38 USD | $138.9 151.84 USD | $334.73B 365.9B USD | 26.20 | $5.3 5.79 USD | |
| AbbVie Inc. ABBV.VI | $167.4 182.99 USD |
-5.28
|
$296.13B 323.71B USD | $0 0 USD | $161.6 176.65 USD | $167.4 182.99 USD | $296.13B 323.71B USD | 76.43 | $2.19 2.39 USD | |
| AbbVie Inc. 4AB.DE | $167.4 182.99 USD |
-5.19
|
$296.13B 323.71B USD | $5.21K 5.7K USD | $156 170.53 USD | $167.4 182.99 USD | $296.13B 323.71B USD | 77.14 | $2.17 2.37 USD | |
| AbbVie Inc. 4AB.F | $165 180.37 USD |
-4.61
|
$291.88B 319.07B USD | $2.4K 2.63K USD | $156 170.53 USD | $165 180.37 USD | $291.88B 319.07B USD | 76.38 | $2.16 2.36 USD | |
| Roche Holding AG ROGN.MX | $6,280.1 371.86 USD |
-6.13
|
$4.87T 288.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.87T 288.48B USD | 26.24 | $239.27 14.17 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZN.BA | $45,750 54.08 USD |
-6.15
|
$235.58T 278.47B USD | $0 0 USD | $0 0 USD | $0 0 USD | $235.58T 278.47B USD | 9.46 | $4.84K 5.72 USD | |
| AstraZeneca PLC AZNN.MX | $1,490 88.23 USD |
0
|
$4.62T 273.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.62T 273.53B USD | 33.22 | $44.85 2.66 USD | |
| Novartis AG NVS.BA | $35,425 41.87 USD |
-4.64
|
$227.25T 268.62B USD | $0 0 USD | $0 0 USD | $0 0 USD | $227.25T 268.62B USD | 2.80 | $12.61K 14.91 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.41T 261.38B USD | 19.08 | $117.11 6.93 USD | |
| Merck & Co., Inc. MRK.BA | $21,725 25.68 USD |
-4.92
|
$220.35T 260.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $220.35T 260.46B USD | 0.30 | $72.42K 85.6 USD | |
| Merck & Co., Inc. MRCK34.SA | $62 12.57 USD |
+1.44
|
$1.25T 253.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.25T 253.95B USD | 13.05 | $4.75 0.96 USD | |
| AstraZeneca PLC A1ZN34.SA | $67.12 13.6 USD |
-3.72
|
$1.25T 253.07B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.25T 253.07B USD | 31.81 | $2.11 0.43 USD | |
| Merck & Co., Inc. MRK.MX | $1,683 99.65 USD |
-2.26
|
$4.25T 251.73B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.25T 251.73B USD | 12.51 | $134.47 7.96 USD | |
| Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.24T 251.12B USD | 18.95 | $3.31 0.67 USD | |
| Roche Holding AG RHHBF | $336.92 — |
+3.67
|
$244.3B — | $50 — | $325 — | $330.5 — | $244.3B — | 28.64 | $11.76 — | |
| Roche Holding AG RHHVF | $302 — |
-0.82
|
$244.3B — | $288 — | $304 — | $312 — | $244.3B — | 25.70 | $11.75 — | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $0 — | $0 — | $243.56B — | 14.30 | $6.74 — | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| AstraZeneca PLC AZNCF | $136.64 — |
-1.02
|
$230.37B — | $100 — | $138.05 — | $138.05 — | $230.37B — | 30.36 | $4.5 — | |
| Roche Holding AG RHO6.F | $32.5 35.53 USD |
-5.99
|
$207.98B 227.35B USD | $72 78.71 USD | $32.5 35.53 USD | $32.65 35.69 USD | $207.98B 227.35B USD | 23.89 | $1.36 1.49 USD | |
| AstraZeneca PLC ZEGA.F | $59.5 65.04 USD |
-4.03
|
$202.73B 221.61B USD | $100 109.31 USD | $59.5 65.04 USD | $59.5 65.04 USD | $202.73B 221.61B USD | 29.16 | $2.04 2.23 USD | |
| AstraZeneca PLC ZEG.F | $119.9 131.07 USD |
-5.14
|
$200.39B 219.05B USD | $4.46K 4.88K USD | $118.65 129.7 USD | $121 132.27 USD | $200.39B 219.05B USD | 29.45 | $4.07 4.45 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.45T 204.53B USD | 42.73 | $150.46 8.91 USD | |
| Merck & Co., Inc. MRK.VI | $73.3 80.13 USD |
-3.17
|
$185.16B 202.4B USD | $969 1.06K USD | $72.4 79.14 USD | $73.3 80.13 USD | $185.16B 202.4B USD | 11.86 | $6.18 6.76 USD | |
| Merck & Co., Inc. 6MK.F | $72.8 79.58 USD |
-2.02
|
$183.9B 201.02B USD | $369 403.37 USD | $72.7 79.47 USD | $73.4 80.24 USD | $183.9B 201.02B USD | 11.93 | $6.1 6.67 USD | |
| Amgen Inc. AMGN.BA | $13,075 15.46 USD |
-3.68
|
$169.91T 200.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $169.91T 200.84B USD | 0.32 | $40.61K 48.01 USD | |
| Novartis AG NOTA.F | $92.2 100.79 USD |
-5.73
|
$182.1B 199.06B USD | $11 12.02 USD | $92 100.57 USD | $92.2 100.79 USD | $182.1B 199.06B USD | 17.33 | $5.32 5.82 USD | |
| Amgen Inc. AMGN34.SA | $61.84 12.53 USD |
+0.24
|
$930.18B 188.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $930.18B 188.53B USD | 40.68 | $1.52 0.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,775 42.29 USD |
-3.31
|
$143.65T 169.8B USD | $0 0 USD | $0 0 USD | $0 0 USD | $143.65T 169.8B USD | 87.71 | $407.84 0.48 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,259.6 133.8 USD |
-0.81
|
$2.82T 166.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.82T 166.79B USD | 294.21 | $7.68 0.45 USD | |
| Pfizer Inc. PFE.BA | $7,700 9.1 USD |
-4.11
|
$140.15T 165.66B USD | $0 0 USD | $0 0 USD | $0 0 USD | $140.15T 165.66B USD | 2.54 | $3.03K 3.58 USD | |
| Gilead Sciences, Inc. GILD34.SA | $318.72 64.6 USD |
-0.45
|
$794.65B 161.06B USD | $0 0 USD | $0 0 USD | $0 0 USD | $794.65B 161.06B USD | 295.11 | $1.08 0.22 USD | |
| Pfizer Inc. PFE.MX | $470.68 27.87 USD |
-3.39
|
$2.67T 158.06B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.67T 158.06B USD | 16.74 | $28.11 1.66 USD | |
| Amgen Inc. AMGN.VI | $268.4 293.4 USD |
-2.45
|
$144.19B 157.61B USD | $1.38K 1.51K USD | $251.45 274.87 USD | $269.65 294.76 USD | $144.19B 157.61B USD | 38.73 | $6.93 7.58 USD | |
| Amgen Inc. AMG.DE | $267.8 292.74 USD |
-2.7
|
$143.86B 157.26B USD | $3.85K 4.21K USD | $250 273.28 USD | $269.8 294.93 USD | $143.86B 157.26B USD | 39.09 | $6.85 7.49 USD | |
| Pfizer Inc. PFIZ34.SA | $33.63 6.82 USD |
-1.29
|
$762.92B 154.63B USD | $0 0 USD | $0 0 USD | $0 0 USD | $762.92B 154.63B USD | 16.98 | $1.98 0.4 USD | |
| Amgen Inc. AMG.F | $255 278.75 USD |
-8.27
|
$136.99B 149.75B USD | $255 278.75 USD | $254 277.66 USD | $255 278.75 USD | $136.99B 149.75B USD | 37.28 | $6.84 7.48 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,675 29.17 USD |
-1.7
|
$120.89T 142.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $120.89T 142.9B USD | 0 | -$4,737 -5.6 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$142.75B — | $0 — | $95.78 — | $95.78 — | $142.75B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.MX | $1,128 66.79 USD |
-7.01
|
$2.3T 135.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.3T 135.9B USD | 0 | -$87.98 -5.2 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $322.11 65.29 USD |
-1.46
|
$655.42B 132.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $655.42B 132.84B USD | 0 | -$24.82 -5.03 USD | |
| Sanofi SNYNF | $103.98 — |
-5.34
|
$132.79B — | $100 — | $103.98 — | $103.98 — | $132.79B — | 21.43 | $4.85 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Sanofi SNW.F | $92.72 101.36 USD |
-0.83
|
$120.76B 132B USD | $1.77K 1.94K USD | $86 94.01 USD | $92.99 101.65 USD | $120.76B 132B USD | 21.12 | $4.39 4.8 USD | |
| Gilead Sciences, Inc. GIS.DE | $96.06 105.01 USD |
-5.28
|
$119.75B 130.9B USD | $11.71K 12.8K USD | $90.73 99.18 USD | $96.47 105.45 USD | $119.75B 130.9B USD | 282.52 | $0.34 0.37 USD | |
| Gilead Sciences, Inc. GILD.VI | $95.95 104.89 USD |
-5.45
|
$119.61B 130.75B USD | $509 556.41 USD | $92.9 101.55 USD | $95.95 104.89 USD | $119.61B 130.75B USD | 274.14 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GIS.F | $95.55 104.45 USD |
-3.48
|
$119.12B 130.21B USD | $1.34K 1.46K USD | $92.31 100.91 USD | $95.65 104.56 USD | $119.12B 130.21B USD | 273.00 | $0.35 0.38 USD | |
| Pfizer Inc. PFE.VI | $20.42 22.32 USD |
-4.22
|
$115.81B 126.6B USD | $3.23K 3.53K USD | $20.09 21.96 USD | $20.45 22.35 USD | $115.81B 126.6B USD | 15.82 | $1.29 1.41 USD | |
| Sanofi SANO.VI | $92.86 101.51 USD |
-4.97
|
$115.72B 126.49B USD | $67 73.24 USD | $92.31 100.91 USD | $92.86 101.51 USD | $115.72B 126.49B USD | 21.15 | $4.39 4.8 USD | |
| Sanofi SNW2.F | $47 51.38 USD |
-5.24
|
$115.39B 126.14B USD | $100 109.31 USD | $47 51.38 USD | $47 51.38 USD | $115.39B 126.14B USD | 21.36 | $2.2 2.4 USD | |
| Pfizer Inc. PFEB.F | $6.3 6.89 USD |
-8.7
|
$107.71B 117.74B USD | $50 54.66 USD | $6.3 6.89 USD | $6.3 6.89 USD | $107.71B 117.74B USD | 14.65 | $0.43 0.47 USD | |
| GSK plc GSK.BA | $12,175 14.39 USD |
-5.44
|
$98.9T 116.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $98.9T 116.9B USD | 27.85 | $437.08 0.52 USD | |
| Bristol-Myers Squibb Company BRM.DE | $49.64 54.26 USD |
-2.84
|
$101.01B 110.41B USD | $1.89K 2.06K USD | $47.01 51.38 USD | $49.64 54.26 USD | $101.01B 110.41B USD | 0 | -$4 -4.3 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $49.23 53.82 USD |
-3.49
|
$100.17B 109.5B USD | $0 0 USD | $47.64 52.07 USD | $49.23 53.82 USD | $100.17B 109.5B USD | 0 | -$4.05 -4.4 USD | |
| Bristol-Myers Squibb Company BRM.F | $47.9 52.36 USD |
-5.01
|
$97.45B 106.53B USD | $60 65.59 USD | $47.9 52.36 USD | $48.2 52.69 USD | $97.45B 106.53B USD | 0 | -$3.99 -4.3 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.52B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.65T 97.52B USD | 25.00 | $32.44 1.92 USD | |
| GSK plc G1SK34.SA | $43.24 8.76 USD |
0
|
$439.04B 88.99B USD | $0 0 USD | $0 0 USD | $0 0 USD | $439.04B 88.99B USD | 23.62 | $1.83 0.37 USD | |
| GSK GLAXF | $18.38 — |
0
|
$77.65B — | $107 — | $20.12 — | $20.16 — | $77.65B — | 22.69 | $0.81 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $38.61 42.21 USD |
-1.91
|
$66.5B 72.69B USD | $30 32.79 USD | $38.06 41.6 USD | $41 44.82 USD | $66.5B 72.69B USD | 26.44 | $1.46 1.6 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $20.12 21.99 USD |
-9.9
|
$37.75B 41.26B USD | $2K 2.19K USD | $20.12 21.99 USD | $20.12 21.99 USD | $37.75B 41.26B USD | 25.15 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $43.8 47.88 USD |
-6.41
|
$23.66B 25.87B USD | $420 459.12 USD | $43.8 47.88 USD | $43.8 47.88 USD | $23.66B 25.87B USD | 11.17 | $3.92 4.29 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $417.75B 24.74B USD | 12.80 | $222.9 13.2 USD | |
| Biogen Inc. BIIB.BA | $12,725 15.04 USD |
-3.78
|
$19.34T 22.86B USD | $0 0 USD | $0 0 USD | $0 0 USD | $19.34T 22.86B USD | 1.05 | $12.01K 14.2 USD | |
| Biogen Inc. BIIB34.SA | $122.52 24.83 USD |
0
|
$108.04B 21.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $108.04B 21.9B USD | 11.72 | $10.45 2.12 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $7,761 21.46 USD |
-4.96
|
$7.62T 21.09B USD | $122 0.34 USD | $7,500 20.74 USD | $7,761 21.46 USD | $7.62T 21.09B USD | 0 | -$1,043.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $19.51 21.33 USD |
-2.79
|
$19.19B 20.98B USD | $18.4K 20.11K USD | $18.66 20.4 USD | $19.75 21.59 USD | $19.19B 20.98B USD | 0 | -$2.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.62 5.05 USD |
-5.71
|
$18.61B 20.35B USD | $1K 1.09K USD | $4.54 4.96 USD | $4.62 5.05 USD | $18.61B 20.35B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. IDP.DE | $110 120.24 USD |
-3.55
|
$16.1B 17.6B USD | $181 197.86 USD | $106.3 116.2 USD | $110 120.24 USD | $16.1B 17.6B USD | 10.85 | $10.13 11.07 USD | |
| Biogen Inc. BIIB.VI | $108.8 118.93 USD |
-4.94
|
$15.93B 17.41B USD | $0 0 USD | $108.35 118.44 USD | $108.8 118.93 USD | $15.93B 17.41B USD | 10.61 | $10.25 11.2 USD | |
| Biogen Inc. IDP.F | $107 116.97 USD |
-5.93
|
$15.66B 17.12B USD | $17 18.58 USD | $107 116.97 USD | $107 116.97 USD | $15.66B 17.12B USD | 10.57 | $10.12 11.06 USD | |
| Astellas Pharma ALPMF | $9.45 — |
0
|
$17.01B — | $1K — | $9.45 — | $9.45 — | $17.01B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPH.F | $7.75 8.47 USD |
-3.41
|
$14.88B 16.27B USD | $27 29.51 USD | $7.75 8.47 USD | $7.75 8.47 USD | $14.88B 16.27B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma Inc. YPHA.F | $7.7 8.42 USD |
-7.78
|
$14.21B 15.53B USD | $0 0 USD | $7.7 8.42 USD | $7.7 8.42 USD | $14.21B 15.53B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,384.4 16.75 USD |
-2.2
|
$1.12T 13.53B USD | $127.21K 1.54K USD | $1,310.05 15.85 USD | $1,401.1 16.95 USD | $1.12T 13.53B USD | 22.43 | $61.72 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $47.96 52.43 USD |
-6.05
|
$9.94B 10.86B USD | $0 0 USD | $47.96 52.43 USD | $47.96 52.43 USD | $9.94B 10.86B USD | 24.10 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $47.24 51.64 USD |
-6.92
|
$9.85B 10.76B USD | $5 5.47 USD | $47.24 51.64 USD | $48.1 52.58 USD | $9.85B 10.76B USD | 23.73 | $1.99 2.18 USD | |
| Orion Oyj ORINY | $31.1 — |
0
|
$8.18B — | $248 — | $31.06 — | $31.06 — | $8.18B — | 24.29 | $1.28 — | |
| CSPC Pharmaceutical CHJTF | $0.56 — |
0
|
$8.11B — | $11K — | $0.93 — | $0.9499 — | $8.11B — | 11.19 | $0.05 — | |
| Orion Oyj OFK.F | $50.75 55.48 USD |
-1.8
|
$7.27B 7.95B USD | $66 72.15 USD | $50.75 55.48 USD | $50.75 55.48 USD | $7.27B 7.95B USD | 21.59 | $2.35 2.57 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.89B — | $316 — | $14.75 — | $14.75 — | $7.89B — | 19.40 | $0.76 — | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Orion Oyj OFK0.F | $24.8 27.11 USD |
-7.46
|
$6.85B 7.49B USD | $0 0 USD | $24.8 27.11 USD | $24.8 27.11 USD | $6.85B 7.49B USD | 21.19 | $1.17 1.28 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $12.4 13.55 USD |
-4.62
|
$6.81B 7.45B USD | $254 277.66 USD | $12.3 13.45 USD | $12.4 13.55 USD | $6.81B 7.45B USD | 17.71 | $0.7 0.77 USD | |
| Abbott India Limited ABBOTINDIA.NS | $28,965.7 350.44 USD |
-0.38
|
$615.5B 7.45B USD | $14.09K 170.42 USD | $27,500.05 332.7 USD | $29,400.05 355.69 USD | $615.5B 7.45B USD | 46.11 | $628.07 7.6 USD | |
| Abbott India Limited ABBOTINDIA.BO | $28,927.9 349.98 USD |
-0.42
|
$614.7B 7.44B USD | $544 6.58 USD | $27,598.55 333.9 USD | $29,299.95 354.48 USD | $614.7B 7.44B USD | 46.10 | $627.46 7.59 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.52 0.56 USD |
-17.79
|
$6.06B 6.62B USD | $23K 25.14K USD | $0.52 0.56 USD | $0.52 0.56 USD | $6.06B 6.62B USD | 10.31 | $0.05 0.05 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $1.85 2.02 USD |
-21.61
|
$5.77B 6.31B USD | $250 273.28 USD | $1.85 2.02 USD | $1.85 2.02 USD | $5.77B 6.31B USD | 10.27 | $0.18 0.2 USD | |
|
لا توجد أسهم مفضَّلة
لا توجد لديك أسهم مفضَّلة حتى الآن؛ لذا يُرجى إضافتها إلى المفضَّلة لرؤيتها هنا |
||||||||||
- {{ link.label }} {{link}}